Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cereblon isoforms and their use as biomarkers for therapeutic treatment

Cereblon isoforms and their use as biomarkers for therapeutic treatment

US Patent 9587281 · Granted Mar 7, 2017

Estimated economic value: $148,475,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for 2025
Transgenic mouse expressing human cereblon2024
Methods, system and computer program product for selectively responding to prese2023
Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for 2023
Combination therapy for the treatment of cancer2022
Combination therapy for the treatment of cancer2022
Combination therapy for the treatment of cancer2022
Treatment of immune-related and inflammatory diseases2022
Treatment of immune-related and inflammatory diseases2022
Treatment of cancer with TOR kinase inhibitors2021
Methods, systems, and networks for authentication based on physical condition of2021
Substitute redundant memory2021